Research Progress of Nervonic Acid Biosynthesis

Area of Science:

• Biotechnology
• Biochemistry
• Synthetic Biology

Background:

• Nervonic acid (NA) is a vital very-long-chain monounsaturated fatty acid crucial for nervous system development and neurological disease treatment.
• Current production relies on chemical synthesis and plant extraction, which are insufficient for market and green industry demands.
• Synthetic biology presents a promising alternative for NA biosynthesis.

Purpose of the Study:

• To review the physicochemical properties, pharmacological activities, and resources of nervonic acid.
• To summarize NA biosynthetic pathways and heterologous biosynthesis strategies.
• To discuss the challenges and future prospects of NA biosynthesis, including cell-free systems and retrobiosynthesis.

Main Methods:

• Literature review of nervonic acid properties, activities, and sources.
• Analysis of existing and potential NA biosynthetic pathways.
• Evaluation of heterologous biosynthesis, cell-free systems, and retrobiosynthesis for NA production.

Main Results:

• Nervonic acid possesses significant therapeutic potential but faces production limitations.
• Synthetic biology approaches offer viable routes for sustainable NA production.
• Cell-free systems and retrobiosynthesis show promise for optimized NA synthesis.

Conclusions:

• Biosynthesis is a key strategy to meet growing demand for nervonic acid.
• Further research in synthetic biology can overcome current production challenges.
• Optimized biosynthesis holds potential for industrial-scale nervonic acid production.